Royal Bank Of Canada Tekla Life Sciences Investors Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Royal Bank Of Canada holds 451,336 shares of HQL stock, worth $6.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
451,336
Previous 73,475
514.27%
Holding current value
$6.03 Million
Previous $932,000
520.28%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding HQL
# of Institutions
84Shares Held
9.08MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.02MShares$40.3 Million0.99% of portfolio
-
Penserra Capital Management LLC Orinda, CA770KShares$10.3 Million0.14% of portfolio
-
Morgan Stanley New York, NY519KShares$6.93 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY431KShares$5.75 Million0.23% of portfolio
-
Needham Investment Management LLC New York, NY392KShares$5.23 Million0.46% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...